These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30563908)

  • 21. Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design.
    Schaefer B; Kisker C; Sotriffer CA
    J Comput Aided Mol Des; 2011 Nov; 25(11):1053-69. PubMed ID: 22076471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis.
    Betts JC; McLaren A; Lennon MG; Kelly FM; Lukey PT; Blakemore SJ; Duncan K
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2903-13. PubMed ID: 12936993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
    Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
    Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates.
    Ho YM; Sun YJ; Wong SY; Lee AS
    Antimicrob Agents Chemother; 2009 Sep; 53(9):4010-2. PubMed ID: 19581462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance.
    Banerjee A; Sugantino M; Sacchettini JC; Jacobs WR
    Microbiology (Reading); 1998 Oct; 144 ( Pt 10)():2697-2704. PubMed ID: 9802011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid.
    Ducasse-Cabanot S; Cohen-Gonsaud M; Marrakchi H; Nguyen M; Zerbib D; Bernadou J; Daffé M; Labesse G; Quémard A
    Antimicrob Agents Chemother; 2004 Jan; 48(1):242-9. PubMed ID: 14693546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.
    Oliveira JS; de Sousa EH; de Souza ON; Moreira IS; Santos DS; Basso LA
    Curr Pharm Des; 2006; 12(19):2409-24. PubMed ID: 16842188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
    Kremer L; Douglas JD; Baulard AR; Morehouse C; Guy MR; Alland D; Dover LG; Lakey JH; Jacobs WR; Brennan PJ; Minnikin DE; Besra GS
    J Biol Chem; 2000 Jun; 275(22):16857-64. PubMed ID: 10747933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.
    Vilchèze C; Morbidoni HR; Weisbrod TR; Iwamoto H; Kuo M; Sacchettini JC; Jacobs WR
    J Bacteriol; 2000 Jul; 182(14):4059-67. PubMed ID: 10869086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
    Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
    Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
    Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
    Vilchèze C; Jacobs WR
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
    Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR
    Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic Insight into how β-Ketoacyl ACP Synthase I (KasA) Recognizes the Fatty Acid Chain Length of its Substrate.
    Lee W
    Chempluschem; 2024 Jul; 89(7):e202300568. PubMed ID: 37983623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).
    Sridharan S; Wang L; Brown AK; Dover LG; Kremer L; Besra GS; Sacchettini JC
    J Mol Biol; 2007 Feb; 366(2):469-80. PubMed ID: 17174327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases.
    Brown AK; Taylor RC; Bhatt A; Fütterer K; Besra GS
    PLoS One; 2009 Jul; 4(7):e6306. PubMed ID: 19609444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III.
    Scarsdale JN; Kazanina G; He X; Reynolds KA; Wright HT
    J Biol Chem; 2001 Jun; 276(23):20516-22. PubMed ID: 11278743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural insight into conformational dynamics of non-active site mutations in KasA: A Mycobacterium tuberculosis target protein.
    Jayaraman M; Rajendra SK; Ramadas K
    Gene; 2019 Dec; 720():144082. PubMed ID: 31476406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrate recognition by β-ketoacyl-ACP synthases.
    Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
    Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.